Suppr超能文献

HAX-1 促进食管鳞癌细胞的化疗耐药性、侵袭性和致瘤性。

HAX-1 promotes the chemoresistance, invasion, and tumorigenicity of esophageal squamous carcinoma cells.

机构信息

Department of Pathophysiology, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.

出版信息

Dig Dis Sci. 2012 Jul;57(7):1838-46. doi: 10.1007/s10620-012-2108-5. Epub 2012 Mar 27.

Abstract

BACKGROUND

HAX-1 is an anti-apoptotic factor and regulates the expression of DNA pol β. Interestingly, DNA polymerase pol β is overexpressed in esophageal squamous cell carcinoma (ESCC). However, the functional role of HAX-1 in ESCC remains unclear.

AIMS

To investigate the role of HAX-1 in chemoresistance, invasion, and tumorigenicity of ESCC.

METHODS

Lentivirus-mediated overexpression or knockdown of HAX-1 was employed to establish ESCC EC9706 cell lines that expressed HAX-1 at different levels. The biological behaviors of these engineered cells were characterized in vitro and in vivo using a xenograft nude mice model. In addition, HAX-1 and pol β expression in the tumor tissues was detected by RT-PCR and immunohistochemistry.

RESULTS

HAX-1 overexpression promoted cell proliferation and resistance against cisplatin, increased cell invasion and suppressed apoptosis along with increased pol β expression. Conversely, HAX-1 knockdown inhibited the malignant phenotypes of EC9706 cells. The xenograft nude mice model demonstrated that HAX-1 overexpression or depletion led to increased or decreased tumor growth in vivo, respectively. Furthermore, a positive correlation of HAX-1 and pol β expression in the tumor tissues was observed.

CONCLUSIONS

HAX-1 promotes the proliferation, chemoresistance, invasion, and tumorigenicity of ESCC, and this is correlated with increased poly β expression. HAX-1 may represent a potential target to overcome the resistance and metastasis of ESCC.

摘要

背景

HAX-1 是一种抗凋亡因子,可调节 DNA 聚合酶 pol β 的表达。有趣的是,DNA 聚合酶 pol β 在食管鳞状细胞癌(ESCC)中过表达。然而,HAX-1 在 ESCC 中的功能作用尚不清楚。

目的

研究 HAX-1 在 ESCC 化疗耐药、侵袭和致瘤性中的作用。

方法

采用慢病毒介导的过表达或敲低 HAX-1,建立 HAX-1 表达水平不同的 ESCC EC9706 细胞系。利用裸鼠异种移植模型,在体外和体内对这些工程细胞的生物学行为进行了特征描述。此外,通过 RT-PCR 和免疫组织化学检测肿瘤组织中 HAX-1 和 pol β 的表达。

结果

HAX-1 过表达促进细胞增殖和对顺铂的耐药性,增加细胞侵袭并抑制凋亡,同时增加 pol β 的表达。相反,HAX-1 敲低抑制了 EC9706 细胞的恶性表型。裸鼠异种移植模型表明,HAX-1 过表达或耗竭分别导致体内肿瘤生长增加或减少。此外,还观察到肿瘤组织中 HAX-1 和 pol β 表达呈正相关。

结论

HAX-1 促进 ESCC 的增殖、化疗耐药性、侵袭和致瘤性,这与 pol β 表达增加有关。HAX-1 可能成为克服 ESCC 耐药性和转移的潜在靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验